Detection of small hypervascular hepatocellular carcinomas by EASL criteria: comparison with double-phase CT during hepatic arteriography
- PMID: 20855175
- DOI: 10.1016/j.ejrad.2010.08.036
Detection of small hypervascular hepatocellular carcinomas by EASL criteria: comparison with double-phase CT during hepatic arteriography
Abstract
Background and aims: To compare the detectability of small hypervascular hepatocellular carcinoma (HCC) between double-phase CT during hepatic arteriography (CTHA) criteria (hypervascular on the early-phase of CTHA and corona enhancement on the late-phase of CTHA) widely introduced in Japan and EASL criteria (hypervascular on the arterial dominant phase and wash out on the equilibrium phase of dynamic CT and/or MRI).
Methods: 116 hypervascular HCC lesions (≤2 cm) of 38 patients were evaluated. CTHA was performed in every patient, both dynamic CT and dynamic MRI in 22 patients, only dynamic CT in 8, and only dynamic MRI in 8. Among them, the detectability of HCC lesions was statistically analyzed with χ2 test.
Results: Double-phase CTHA detected all HCCs. Dynamic CT revealed 38 (40%) of 95 small HCCs; during dynamic MRI 38 (40%) of 95 small HCCs were detected. The difference between dynamic CT or dynamic MRI and CTHA was statistically significant (p<0.05).
Conclusion: The detectability of small hypervascular HCC on dynamic CT and dynamic MRI was almost the same and significantly lower as compared to that of CTHA. When comparing differences in the results of HCC treatment, differences in the diagnostic criteria applied should always be kept in mind.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Optimal scan timing for coronal enhancement of hypervascular hepatocellular carcinomas and correlation with tumor size: evaluation with four-phase CT hepatic arteriography.Radiat Med. 2005 Sep;23(6):456-62. Radiat Med. 2005. PMID: 16389992 Clinical Trial.
-
Combination of CT during arterial portography and double-phase CT hepatic arteriography with multi-detector row helical CT for evaluation of hypervascular hepatocellular carcinoma.Clin Radiol. 2007 Dec;62(12):1189-97. doi: 10.1016/j.crad.2007.05.005. Epub 2007 Oct 1. Clin Radiol. 2007. PMID: 17981167
-
Clinical Indication for Computed Tomography During Hepatic Arteriography (CTHA) in Addition to Dynamic CT Studies to Identify Hypervascularity of Hepatocellular Carcinoma.Cardiovasc Intervent Radiol. 2018 Apr;41(4):618-627. doi: 10.1007/s00270-017-1832-9. Epub 2017 Nov 3. Cardiovasc Intervent Radiol. 2018. PMID: 29101449
-
Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens.Intervirology. 2004;47(3-5):199-208. doi: 10.1159/000078473. Intervirology. 2004. PMID: 15383730 Review.
-
CT Imaging of early hepatocellular carcinoma and the natural outcome of hypoattenuating nodular lesions in chronic liver disease.Oncology. 2007;72 Suppl 1:83-91. doi: 10.1159/000111712. Epub 2007 Dec 13. Oncology. 2007. PMID: 18087187 Review.
Cited by
-
APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review.Int J Hepatol. 2011;2011:519783. doi: 10.4061/2011/519783. Epub 2011 Apr 19. Int J Hepatol. 2011. PMID: 22007313 Free PMC article.
-
Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.Eur Radiol. 2015 Nov;25(11):3123-32. doi: 10.1007/s00330-015-3732-1. Epub 2015 Apr 23. Eur Radiol. 2015. PMID: 25903707
-
Hemodynamics and progression of a hypervascular focus in a borderline lesion of hepatocellular carcinoma: analysis by angiography-assisted CT and histopathology.Jpn J Radiol. 2014 Feb;32(2):69-79. doi: 10.1007/s11604-013-0268-7. Epub 2013 Dec 12. Jpn J Radiol. 2014. PMID: 24337887
-
Optimal injection rate and volume of contrast medium for observing hemodynamics of a hepatocellular carcinoma structure model.Radiol Phys Technol. 2013 Jan;6(1):78-85. doi: 10.1007/s12194-012-0172-3. Epub 2012 Aug 8. Radiol Phys Technol. 2013. PMID: 22872421
-
Diagnostic performance of gadoxetic acid (Primovist)-enhanced MR imaging versus CT during hepatic arteriography and portography for small hypervascular hepatocellular carcinoma.Medicine (Baltimore). 2016 Sep;95(39):e4903. doi: 10.1097/MD.0000000000004903. Medicine (Baltimore). 2016. PMID: 27684824 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical